Dr. Janvi Hemantkumar Wadiwala, MD

Dr. Wadiwala practices at Atrium Health Navicent The Medical Center in Macon, Georgia, part of Advocate Health.

Dr. Wadiwala's NPI, 1457914616, was assigned on April 15, 2019. Dr. Wadiwala holds Georgia license 91251.

Dr. Wadiwala's primary practice is Atrium Health Navicent the Medical Center, at 777 Hemlock Street, Macon, GA 31201 in Bibb County. The practice phone is (478) 633-1000.

Dr. Wadiwala's primary practice is Atrium Health Navicent The Medical Center in Macon, Georgia, part of Advocate Health. Dr. Wadiwala is also affiliated with Emory Hospital Warner Robins. The medical group on file is Piedmont Hospitalist Physicians Group. Dmand AI also links Dr. Wadiwala to 1 more hospital, 5 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wadiwala practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Wadiwala's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Wadiwala is licensed in Georgia.

CMS data shows 385 Medicare services from Dr. Wadiwala across 4 procedure codes in 2024, for 144 Medicare patients. Medicare paid $29,271 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Wadiwala in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wadiwala's median patient age at 67, with 51% women.

In 2024, Dr. Wadiwala wrote 204 Medicare Part D claims for 100 patients. 89% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $70 in total drug cost. In 2023, CMS named 119 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wadiwala for performance year 2024, reported through an alternative payment model (APM). Dr. Wadiwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Wadiwala from 9 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $78.